Duc M. Hoang
VietnameseInternal medicinePublic healthPathologyOncologyCellRandomized controlled trialStromal cellAdipose tissueCryopreservationChemistryPediatricsAdverse effectMesenchymal stem cellCOPDUmbilical cordObstructive lung diseaseLungAutism spectrum disorderBronchopulmonary dysplasiaAutologous stem-cell transplantationHLA-DRStem-cell therapyBone marrowStem cellPopulationExtreme Preterm BirthAllogeneic transplantationType 2 Diabetes MellitusLung injuryXeno freeSerum freeIncidence (epidemiology)Cancer researchDiabetes mellitusMedicineBiomarker (medicine)Complication
6Publications
1H-index
3Citations
Publications 7
Newest
#2Van T. HoangH-Index: 2
view all 10 authors...
Source
#1Liem NguyenH-Index: 4
#2Duc M. HoangH-Index: 1
Last. Anh Viet BuiH-Index: 1
view all 21 authors...
Human bone marrow-derived mesenchymal stem/stromal cells (BM-MSCs) represent promising stem cell therapy for the treatment of type 2 diabetes mellitus (T2DM), but the results of autologous BM-MSC administration in T2DM patients are contradictory. The purpose of this study was to test the hypothesis that autologous BM-MSC administration in T2DM patient is safe and that the efficacy of the treatment is dependant on the quality of the autologous BM-MSC population and administration routes. T2DM pat...
Source
#1Duc M. HoangH-Index: 1
#2Kien T. NguyenH-Index: 14
Last. Liem Thanh NguyenH-Index: 2
view all 5 authors...
Introduction The global prevalence of chronic obstructive pulmonary disease (COPD) is increasing, and it has become a major public health burden worldwide, including in Vietnam. A large body of preclinical and clinical studies supports the safety of mesenchymal stem/stromal cells (MSCs) in the treatment of lung injury, including COPD. The aim of this trial is to investigate the safety and potential therapeutic efficacy of allogeneic administration of umbilical cord-derived MSCs (UC-MSCs) as a su...
Source
#1Liem NguyenH-Index: 4
#1Liem Thanh NguyenH-Index: 2
Last. Duc M. HoangH-Index: 1
view all 3 authors...
Source
#1Van T. HoangH-Index: 2
#1Van T. HoangH-Index: 2
Last. Duc M. HoangH-Index: 1
view all 13 authors...
Abstract Background aims Mesenchymal stem/stromal cells (MSCs) are of interest for the treatment of graft-versus-host disease, autoimmune diseases, osteoarthritis and neurological and cardiovascular diseases. Increasing numbers of clinical trials emphasize the need for standardized manufacturing of these cells. However, many challenges related to diverse isolation and expansion protocols and differences in cell tissue sources exist. As a result, the cell products used in numerous trials vary gre...
2 CitationsSource
Background Bronchopulmonary dysplasia (BPD) is a severe condition in premature infants that compromises lung function and necessitates oxygen support. Despite major improvements in perinatal care minimizing the devastating effects, BPD remains the most frequent complication of extreme preterm birth. Our study reports the safety of the allogeneic administration of umbilical cord-derived mesenchymal stem/stromal cells (allo-UC-MSCs) and the progression of lung development in four infants with esta...
1 CitationsSource
#1Liem Nguyen ThanhH-Index: 4
Last. Duc M. HoangH-Index: 1
view all 8 authors...
Source